MDL® offers DiscoveryGate research platform to academia
Premier chemical information resource opened to students and faculty at institutions worldwide.
San Leandro, CA— March 29, 2004 — MDL Information Systems, Inc. (MDL®), an Elsevier company, has announced availability of its premier Web-based research platform to the academic community. DiscoveryGate, the structure-searchable resource for scientific information that has become a first stop for corporate scientists, is now open to students, faculty, and academic researchers worldwide.
“MDL is proud to make this resource available and affordable to the academic community,” said MDL CEO Bernard Aleva. “DiscoveryGate is unparalleled in its delivery of integrated, indexed content from Elsevier and MDL and other content providers including Thomson Derwent, Prous, FIZ Chemie, Springer, and Wiley.”
Academic researchers can now access 14 databases such as CrossFire Beilstein, MDL® Available Chemicals Directory, MDL® Drug Data Report, and MDL® Toxicity, authoritative reference works, and links to over 20,000 journal titles (additional licenses required to access third-party content in their environments).
DiscoveryGate does not merely provide author abstracts and indexed text records, but richly-excerpted information from the areas of chemistry, synthesis, ADME, toxicology, and pharmacology. With DiscoveryGate’s integration and linking of content, researchers can quickly compare results and information not available through other systems. DiscoveryGate gives researchers access to more than 13 million chemical structures, 10 million reactions, and over 200 million associated calculated and reported properties, including synthesis, bioactivity, metabolism, toxicology, and physical property data.
DiscoveryGate for academia ( gateway.discoverygate.com) features a campus-wide access model: When an institution licenses DiscoveryGate, any number of eligible faculty members, students, or researchers at the institution may simultaneously use it—access is not limited to a few people at a time.
“This is a tremendous boost for librarians, chemistry students, and faculty researchers,” said Tim Hoctor, product manager for MDL. “The system is affordable for institutions, management is simple, and availability to researchers is assured.”
With the new DiscoveryGate offering to academia, researchers can access structures and data with a simple query, perform structure-based clustering of results sets, quickly acquire a summary view of relevant data, and easily generate standardized reports. For an interactive tour of DiscoveryGate visit www.discoverygate.com.
MDL is a wholly owned subsidiary of Elsevier and its products and services are part of Elsevier’s life sciences portfolio. This portfolio combines extensive MDL informatics, database, workflow, and decision support solutions with Elsevier’s 400 chemistry and life science journals and related products—accelerating the discovery and development of innovative and successful new drugs by improving the speed and quality of scientists’ decision making.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group plc, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.
MDL Information Systems, Inc.
(510) 895-1313 ext. 1371